ABSTRACT
OBJECTIVE To characterize adult and older adult vaccination practices of physicians, from various medical specialties, in Brazil; identify barriers influencing prescription of vaccines to these populations, and evaluate the physicians’ knowledge on routinely prescribed vaccines.
METHODS Cross-sectional survey conducted in Brazil between June-August 2018. Eligible physicians included those from general practice/family medicine, geriatrics, cardiology, gynecology, endocrinology, infectious disease and pulmonology. The survey’s questions addressed the physicians’ prescription habits, sociodemographic and clinical practice characteristics, barriers to vaccines’ prescription, and physicians’ knowledge regarding routinely prescribed vaccines. The study focused on the vaccines recommended by the Brazilian Society of Immunization (SBIm) for adults and older adults (years 2017-2018). Study sample was stratified according to the number of physicians per specialty and Brazilian region.
RESULTS A total of 1068 surveys were completed. The vaccines prescribed by the highest proportions of physicians were Influenza (>90% of physicians for adults and older adults), Hepatitis B (adults: 87%; older adults: 59%) and Yellow Fever (adults: 77.7%; older adults: 58.5%). Underprescription was reported by less than 20% of prescribing physicians for all adult and older adult recommended vaccines. The most common barriers to vaccination were the high vaccine cost, lack of time during appointments and lack of patient interest. Knowledge on target populations, dosage schedule and availability in the Unified Public Health System (SUS) was generally low.
CONCLUSIONS The results showed a considerable variability of prescribing habits across recommended vaccines. Although most prescribing physicians seem to be aware of the importance of adult and older adult vaccination, knowledge deficits on vaccines’ target populations, dosage schedule and availability in the SUS may hamper their ability to prescribe vaccines to all patients with an indication.
Competing Interest Statement
Fernando B Serra, Paula M Batista and Thais N F Moreira are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA, who may own stock and/or hold stock options in Merck & Co., Inc., Kenilworth, NJ, USA. Diogo Ribeiro is an employee of CTI Clinical Trial & Consulting Services. This company received honoraria from the project funder for support in the study planning and manuscript development.
Funding Statement
Fernando B Serra, Paula M Batista and Thais N F Moreira are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA, who may own stock and/or hold stock options in Merck & Co., Inc., Kenilworth, NJ, USA. Diogo Ribeiro is an employee of CTI Clinical Trial & Consulting Services. This company received honoraria from the project funder for support in the study planning and manuscript development.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of Universidade Federal de Sao Paulo
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Authors’ emails and phone numbers: Fernando B Serra – fernando.brandao.serra{at}merck.com; (55)11 5189 7584
Diogo Ribeiro – dribeiro{at}ctifacts.com; (351) 21 382 54 40
Paula M Batista – paula.de.mendonca.batista{at}merck.com; (55) 11 5189 7679
Thais N F Moreira – thais.moreira{at}merck.com; (55) 11 5189 7204
Data Availability
not applicable.
